Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Lepu Medical: The Radiofrequency Skin Treatment Device "Celtie" Receives NMPA Registration Approval
Lepu Medical announced that its subsidiary Sichuan Xingtaipu Le Medical Technology Co., Ltd. independently developed the “Sailite” radiofrequency skin treatment device (commonly known as “Thermage”) has received registration approval from the National Medical Products Administration (NMPA), with registration certificate number: Guo Xie Zhun 20263090882. This product is used in medical institutions by qualified medical personnel after training, utilizing radiofrequency energy to generate heat effects on skin tissue, aimed at reducing mild to moderate facial skin wrinkles. The successful approval of the radiofrequency skin treatment device further enriches the company’s product portfolio in the dermatology field and will work synergistically with existing products to meet the increasingly diverse market demands, aiding the company’s expansion in the consumer healthcare sector. It is expected to have a positive impact on the company’s development.